Kasper; Lloyd H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kasper; Lloyd H..The latest application filed is for "nutraceutical composition and methods for prevention or treating multiple sclerosis".

Company Profile

0.12.14

Kasper; Lloyd H. - Norwhich VT US
Kasper; Lloyd H. - Norwich VT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate Grant 9,625,473 - Kasper , et al. April 18, 2	2017-04-18
Nutraceutical Composition And Methods For Prevention Or Treating Multiple Sclerosis App 20160158269 - Kasper; Lloyd H. ; et al.	2016-06-09
Nutraceutical Composition And Methods For Preventing Or Treating Multiple Sclerosis App 20160143941 - Kasper; Lloyd H. ; et al.	2016-05-26
Cytokine Biomarkers As Predictive Biomarkers Of Clinical Response For Glatiramer Acetate App 20150241446 - Kasper; Lloyd H. ; et al.	2015-08-27
Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate Grant 9,063,153 - Kasper , et al. June 23, 2	2015-06-23
Cytokine Biomarkers As Predictive Biomarkers Of Clinical Response For Glatiramer Acetate App 20140294899 - Kasper; Lloyd H. ; et al.	2014-10-02
Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate Grant 8,709,433 - Kasper , et al. April 29, 2	2014-04-29
Method For Stimulating Foxp3+ Regulatory T Cell Expression Of Cd39 App 20140030807 - Kasper; Lloyd H. ; et al.	2014-01-30
Prevention or treatment of immune-relevant disease by modification of microfloral populations Grant 8,586,029 - Kasper , et al. November 19, 2	2013-11-19
Nutraceutical composition and methods for preventing or treating multiple sclerosis Grant 8,580,278 - Kasper , et al. November 12, 2	2013-11-12
Cytokine Biomarkers As Predictive Biomarkers Of Clinical Response For Glatiramer Acetate App 20120121619 - Kasper; Lloyd H. ; et al.	2012-05-17
Nutraceutical Composition and Methods for Preventing or Treating Multiple Sclerosis App 20120094950 - Kasper; Lloyd H. ; et al.	2012-04-19
Prevention or Treatment of Immune-Relevant Disease by Modification of Microfloral Populations App 20110086011 - Kasper; Lloyd H. ; et al.	2011-04-14
Nutraceutical Composition and Methods for Preventing or Treating Multiple Sclerosis App 20110009360 - Kasper; Lloyd H. ; et al.	2011-01-13
Nutraceutical composition and methods for preventing or treating multiple sclerosis App 20100311686 - Kasper; Lloyd H. ; et al.	2010-12-09
Method Of Augmenting T Cell-mediated Immunity Against Toxoplasma Gondii App 20020031519 - KASPER, LLOYD H. ; et al.	2002-03-14
P30 peptides of Toxoplasma gondii Grant 5,859,196 - Boothroyd , et al. January 12, 1	1999-01-12
Diagnostic genes for toxoplasmosis Grant 5,629,414 - Boothroyd , et al. May 13, 1	1997-05-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.